2-Benzylhexahydro-1H-isoindol-4(2H)-one, 95.0%, 100mg

N,N,2-Trimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, 98%, 5g

[(2E)-3-(2-methoxyphenyl)prop-2-en-1-yl](propyl)amine hydrochloride, 95.0%, 1g

1-Pyrenebutyric Acid>98.0%(GC)(T)1g

1-(2-Aminobenzo[d]thiazol-6-yl)ethan-1-one, 95+%, 25g

5-Nitro-1,2,3,4-tetrahydroisoquinoline, 95.0%, 50mg

Lámina de vanadio 99,9+% 2,0 x 100 x 100 mm 1 ud

(R)-methyl 2-(6-hydroxy-2,3-dihydrobenzofuran-3-yl)acetate, 95%, 100mg

ethyl 3-aminopyrazine-2-carboxylate, 95.0%, 1g

4-Furan-2-yl-pyrimidine-2-thiol, 97.0%, 5g

(4S,4'S)-2,2'-(1,3-Bis(4-(tert-butyl)phenyl)propane-2,2-diyl)bis(4-methyl-4,5-dihydrooxazole), 97%, 100mg

2-Methoxy-nicotinic acid, 99.00%, 5g

3-Bromopyridine-4-carboxaldehyde>98.0%(GC)1g